Comparison of TAVR and SAVR in elderly patients with pure native aortic regurgitation: outcomes and midterm results.

ABSTRACT:

Background

Aortic regurgitation (AR) is a common valvular disease, but data comparing surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) for pure native AR are limited. The aim of this study is to provide more robust evidence for employing TAVR in patients with pure native AR.

Methods

This retrospective cohort study included 208 elderly patients (≥65 years) with pure native AR who underwent elective aortic valve replacement (SAVR or TAVR, all patients underwent TAVR procedure using the J-Valve™ system) between January 2018 and June 2023 at Beijing Anzhen Hospital, China. Safety and hemodynamic outcomes were assessed up to 3.1 years [interquartile range (IQR), 1.9-4.8 years], with propensity score weighting used to adjust for confounder

SUBMITTER: Zhao C 

PROVIDER: S-EPMC12596466 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature